Skip to main content
Erschienen in: Medical Oncology 2/2009

01.06.2009 | Case Report

Primary extragastrointestinal stromal tumor of the transverse mesocolon without c-kit mutations but with PDGFRA mutations

verfasst von: Tadashi Terada

Erschienen in: Medical Oncology | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

The author reports a rare case of primary large cystic extragastrointestinal stromal tumor (eGIST) of the transverse mesocolon with genetic analyses of the c-kit and platelet-derived growth factor receptor-α (PDGFRA) genes. A 78-year-old man was found to have a large cystic tumor in the abdomen, and the tumor was resected. Grossly, the tumor was located in the transverse mesocolon, and cystic. Microscopically, the tumor consisted of epithelioid cells with atypia. Mitotic figures were noted in five of 50 high power fields. Immunohistochemically, the tumor cells were positive for KIT, CD34, PDGFRA, and vimentin, but negative for cytokeratins, neuron specific enolase, desmin, S100 protein, α-smooth muscle actin, p53 protein, HMB45, CD68, CEA, factor VIII-related antigen, chromogranin, and synaptophysin. Ki67 labeling was 5%. Genetically, the tumor showed a point mutation (GAC → GTC) at codon 842 of exon 18 of the PDGFRA gene. Exon 12 of the PDGFRA gene and exons 9, 11, 13, and 17 of the c-kit gene showed no mutations. No recurrence is noted 3 years after the operation. This case shows that eGIST may occur in the transverse mesocolon.
Literatur
1.
2.
Zurück zum Zitat Losota J, Miettinen M. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs). Semin Diagn Pathol. 2006;23:91–101.CrossRef Losota J, Miettinen M. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs). Semin Diagn Pathol. 2006;23:91–101.CrossRef
3.
Zurück zum Zitat Miettinen M, Lasota J. Gastrointestinal stromal tumor: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130:1466–78.PubMed Miettinen M, Lasota J. Gastrointestinal stromal tumor: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130:1466–78.PubMed
4.
Zurück zum Zitat Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumor. Science. 1998;279:577–80.CrossRefPubMed Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumor. Science. 1998;279:577–80.CrossRefPubMed
5.
Zurück zum Zitat Hirota S, Ohashi A, Nishida T, Isozaki K, Kinoshita K, Shinomura Y, et al. Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumor. Gastroenterology. 2003;125:660–7.CrossRefPubMed Hirota S, Ohashi A, Nishida T, Isozaki K, Kinoshita K, Shinomura Y, et al. Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumor. Gastroenterology. 2003;125:660–7.CrossRefPubMed
6.
Zurück zum Zitat Hu X, Forster J, Damajanov I. Primary malignant gastrointestinal stromal tumor of the liver. Arch Pathol Lab Med. 2003;127:1606–8.PubMed Hu X, Forster J, Damajanov I. Primary malignant gastrointestinal stromal tumor of the liver. Arch Pathol Lab Med. 2003;127:1606–8.PubMed
7.
Zurück zum Zitat Mendoza-Marin M, Hoang MP, Albores-Saavedra J. Malignant stromal tumor of the gall bladder with interstitial cells of Cajal phenotype. Arch Pathol Lab Med. 2002;126:481–2.PubMed Mendoza-Marin M, Hoang MP, Albores-Saavedra J. Malignant stromal tumor of the gall bladder with interstitial cells of Cajal phenotype. Arch Pathol Lab Med. 2002;126:481–2.PubMed
8.
Zurück zum Zitat Ortiz-Hidalgo C, de Leon Borjorge B, Albores-Saavedra J. Stromal tumor of the gall bladder with phenotype of interstitial cells of Cajal: a previously unrecognized neoplasm. Am J Surg Pathol. 2000;24:1420–3.CrossRefPubMed Ortiz-Hidalgo C, de Leon Borjorge B, Albores-Saavedra J. Stromal tumor of the gall bladder with phenotype of interstitial cells of Cajal: a previously unrecognized neoplasm. Am J Surg Pathol. 2000;24:1420–3.CrossRefPubMed
9.
Zurück zum Zitat Yamaura K, Kato M, Miyazawa M, Haba Y, Muramatsu A, Miyata K, et al. Stromal tumor of the pancreas with expression of c-kit protein: report of a case. J Gastroenterol Hepatol. 2004;19:467–70.CrossRefPubMed Yamaura K, Kato M, Miyazawa M, Haba Y, Muramatsu A, Miyata K, et al. Stromal tumor of the pancreas with expression of c-kit protein: report of a case. J Gastroenterol Hepatol. 2004;19:467–70.CrossRefPubMed
10.
Zurück zum Zitat Daum O, Klecka J, Ferda J, Treska V, Vanecek T, Sima R, et al. Gastrointestinal stromal tumor of the pancreas: case report with documentation of KIT gene mutations. Virchows Archiv. 2005;446:470–2.CrossRefPubMed Daum O, Klecka J, Ferda J, Treska V, Vanecek T, Sima R, et al. Gastrointestinal stromal tumor of the pancreas: case report with documentation of KIT gene mutations. Virchows Archiv. 2005;446:470–2.CrossRefPubMed
11.
Zurück zum Zitat Miettinen M, Monihan JM, Sarlomo-Rikala M, Kovatich AJ, Carr NJ, Emory TS, et al. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathological and immunohistochemical study of 26 cases. Am J Surg Pathol. 1999;23:1109–18.CrossRefPubMed Miettinen M, Monihan JM, Sarlomo-Rikala M, Kovatich AJ, Carr NJ, Emory TS, et al. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathological and immunohistochemical study of 26 cases. Am J Surg Pathol. 1999;23:1109–18.CrossRefPubMed
12.
Zurück zum Zitat Jakobs K, Gheldere CD, Vanclooster P. A ruptured gastrointestinal stromal tumor of the transverse colon: a case report. Acta Chir Belg. 2006;106:218–21. Jakobs K, Gheldere CD, Vanclooster P. A ruptured gastrointestinal stromal tumor of the transverse colon: a case report. Acta Chir Belg. 2006;106:218–21.
13.
Zurück zum Zitat Paparelli C, Cavallaro G, Basso L, Polistena A, Mingazzini P, De Toma G. Giant GIST of the mesocolon, report of a case. Minerva Chir. 2006;61:537–40.PubMed Paparelli C, Cavallaro G, Basso L, Polistena A, Mingazzini P, De Toma G. Giant GIST of the mesocolon, report of a case. Minerva Chir. 2006;61:537–40.PubMed
14.
Zurück zum Zitat Terada T, Kawaguchi M, Furukawa K, Sekido Y, Osamura Y. Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth. Pathol Int. 2002;52:740–6.CrossRefPubMed Terada T, Kawaguchi M, Furukawa K, Sekido Y, Osamura Y. Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth. Pathol Int. 2002;52:740–6.CrossRefPubMed
15.
Zurück zum Zitat Terada T, Kawaguchi M. Primary clear cell adenocarcinoma of the peritoneum. Tohoku J Exp Med. 2005;271:271–5.CrossRef Terada T, Kawaguchi M. Primary clear cell adenocarcinoma of the peritoneum. Tohoku J Exp Med. 2005;271:271–5.CrossRef
16.
Zurück zum Zitat Terada T (2008). Gastrointestinal stromal tumor of the uterus: a case report with genetic analyses of c-kit and PDGFRA genes. Int J Gynecol Oncol (in press). Terada T (2008). Gastrointestinal stromal tumor of the uterus: a case report with genetic analyses of c-kit and PDGFRA genes. Int J Gynecol Oncol (in press).
17.
Zurück zum Zitat Kim JH, Boo YJ, Jung CW, Park SS, Kim SJ, Mok YJ, et al. Multiple malignant extragastrointestinal stromal tumors of the greater omentum and results of immunohistochemistry and mutation analysis: a case report. World J Gastroenterol. 2007;13:3392–5.PubMed Kim JH, Boo YJ, Jung CW, Park SS, Kim SJ, Mok YJ, et al. Multiple malignant extragastrointestinal stromal tumors of the greater omentum and results of immunohistochemistry and mutation analysis: a case report. World J Gastroenterol. 2007;13:3392–5.PubMed
18.
Zurück zum Zitat Yamamoto H, Oda Y, Kawagichi K, Nakamura N, Takahira T, Tamiya S, et al. c-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue). Am J Surg Pathol. 2004;28:479–88.CrossRefPubMed Yamamoto H, Oda Y, Kawagichi K, Nakamura N, Takahira T, Tamiya S, et al. c-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue). Am J Surg Pathol. 2004;28:479–88.CrossRefPubMed
19.
Zurück zum Zitat Dow N, Giblen G, Sobin LS, Miettinen M. Gastrointestinal stromal tumors: differential diagnosis. Semin Diagn Pathol. 2006;23:111–9.CrossRefPubMed Dow N, Giblen G, Sobin LS, Miettinen M. Gastrointestinal stromal tumors: differential diagnosis. Semin Diagn Pathol. 2006;23:111–9.CrossRefPubMed
20.
Zurück zum Zitat Ciontea SM, Radu E, Regalia T, Ceafalan L, Cretoiu D, Gherghiceanu M, et al. C-kit immunopositive interstitial cells (Cajal-type) in human myometrium. J Cell Mol Med. 2005;9:407–20.CrossRefPubMed Ciontea SM, Radu E, Regalia T, Ceafalan L, Cretoiu D, Gherghiceanu M, et al. C-kit immunopositive interstitial cells (Cajal-type) in human myometrium. J Cell Mol Med. 2005;9:407–20.CrossRefPubMed
21.
Zurück zum Zitat Huizinga JD, Faussone-Pellegrini MS. About the presence of interstitial cells of Cajal outside the musculature of the gastrointestinal tract. J Cell Mol Med. 2005;9:468–73.CrossRefPubMed Huizinga JD, Faussone-Pellegrini MS. About the presence of interstitial cells of Cajal outside the musculature of the gastrointestinal tract. J Cell Mol Med. 2005;9:468–73.CrossRefPubMed
22.
Zurück zum Zitat Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB–1 grade. Hum Pathol. 2002;33:669–76.CrossRefPubMed Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB–1 grade. Hum Pathol. 2002;33:669–76.CrossRefPubMed
23.
Zurück zum Zitat Sakurai S, Hishima T, Takazawa Y, Sano T, Nakajima T, Saito K, et al. Gastrointestinal stromal tumor and KIT-positive mesenchymal cells in the omentum. Pathol Int. 2001;51:524–31.CrossRefPubMed Sakurai S, Hishima T, Takazawa Y, Sano T, Nakajima T, Saito K, et al. Gastrointestinal stromal tumor and KIT-positive mesenchymal cells in the omentum. Pathol Int. 2001;51:524–31.CrossRefPubMed
24.
Zurück zum Zitat Min KW, Leabu M. Interstitial cells of Cajal (ICC) and gastrointestinal stromal tumor (GIST): facts, speculation, and myths. J Cell Mol Med. 2006;10:995–1013.CrossRefPubMed Min KW, Leabu M. Interstitial cells of Cajal (ICC) and gastrointestinal stromal tumor (GIST): facts, speculation, and myths. J Cell Mol Med. 2006;10:995–1013.CrossRefPubMed
25.
Zurück zum Zitat Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical and molecular study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29:52–68.CrossRefPubMed Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical and molecular study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29:52–68.CrossRefPubMed
26.
Zurück zum Zitat Singer S, Rubin BP, Lux ML, Chen CJ, Demetri GD, Fletcher JA. Prognostic value of KIT mutation type, mitotic activity and histological subtype in gastrointestinal stromal tumor. J Clin Oncol. 2002;20:3898–905.CrossRefPubMed Singer S, Rubin BP, Lux ML, Chen CJ, Demetri GD, Fletcher JA. Prognostic value of KIT mutation type, mitotic activity and histological subtype in gastrointestinal stromal tumor. J Clin Oncol. 2002;20:3898–905.CrossRefPubMed
Metadaten
Titel
Primary extragastrointestinal stromal tumor of the transverse mesocolon without c-kit mutations but with PDGFRA mutations
verfasst von
Tadashi Terada
Publikationsdatum
01.06.2009
Verlag
Humana Press Inc
Erschienen in
Medical Oncology / Ausgabe 2/2009
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-008-9092-9

Weitere Artikel der Ausgabe 2/2009

Medical Oncology 2/2009 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.